Svetlana A Gorbunova, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Svetlana A Gorbunova’s office to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$136,020
Pharmacies billed $136,020 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
869 generic and fewer than 11 brand-name prescriptions · $136,020 in drug cost · 54 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 21 | $17,342 | $826 |
| Tacrolimus | 42 | $9,461 | $225 |
| Valganciclovir | 41 | $9,445 | $230 |
| Everolimus | 12 | $8,605 | $717 |
| Mycophenolate Mofetil | 13 | $3,951 | $304 |
See all 25 drugs
| Farxiga | 21 | $17,342 | $826 |
| Tacrolimus | 42 | $9,461 | $225 |
| Valganciclovir | 41 | $9,445 | $230 |
| Everolimus | 12 | $8,605 | $717 |
| Mycophenolate Mofetil | 13 | $3,951 | $304 |
| Warfarin | 155 | $1,979 | $13 |
| Nystatin | 26 | $1,275 | $49 |
| Pravastatin | 70 | $1,033 | $15 |
| Potassium Chloride | 38 | $898 | $24 |
| Bumetanide | 16 | $882 | $55 |
| Pantoprazole | 85 | $857 | $10 |
| Hydralazine | 19 | $598 | $31 |
| Levothyroxine | 11 | $561 | $51 |
| Losartan | 31 | $315 | $10 |
| Atorvastatin | 23 | $218 | $9 |
| Furosemide | 33 | $214 | $6 |
| Sulfamethoxazole-Trimethoprim | 32 | $205 | $6 |
| Carvedilol | 18 | $200 | $11 |
| Spironolactone | 23 | $195 | $8 |
| Digoxin | 15 | $183 | $12 |
| Rosuvastatin | 11 | $178 | $16 |
| Lisinopril | 17 | $156 | $9 |
| Prednisone | 16 | $65 | $4 |
| Amlodipine Besylate | 14 | $47 | $3 |
| Allopurinol | 14 | $44 | $3 |
Year by year
| 2024 | 937 | 124 | None | None | $136,020 |
| 2023 | 544 | 104 | 0% (0) | None | $137,996 |
| 2022 | 420 | 68 | None | 13% | $144,078 |
| 2021 | 254 | 50 | 0% (0) | 11% | $49,227 |
| 2020 | 191 | 37 | None | 16% | $13,544 |
| 2019 | 152 | 36 | None | 18% | $10,619 |
| 2018 | 195 | 45 | None | None | $9,602 |
| 2017 | 65 | 21 | None | 18% | $5,415 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Entresto | 13 | $12,968 | $998 |
| Farxiga | 16 | $12,781 | $799 |
| Tacrolimus | 34 | $6,375 | $187 |
| Warfarin | 77 | $2,640 | $34 |
| Potassium Chloride | 28 | $984 | $35 |
| Pravastatin | 32 | $845 | $26 |
| Hydralazine | 18 | $748 | $42 |
| Atorvastatin | 27 | $620 | $23 |
| Carvedilol | 21 | $495 | $24 |
| Losartan | 22 | $461 | $21 |
| Nystatin | 11 | $401 | $36 |
| Pantoprazole | 30 | $380 | $13 |
| Furosemide | 15 | $315 | $21 |
| Sulfamethoxazole-Trimethoprim | 19 | $198 | $10 |
| Amlodipine Besylate | 17 | $118 | $7 |
2022: 10 drugs
| Sandostatin Lar Depot | 11 | $47,304 | $4,300 |
| Valganciclovir | 21 | $6,320 | $301 |
| Tacrolimus | 28 | $2,911 | $104 |
| Warfarin | 46 | $902 | $20 |
| Pantoprazole | 41 | $526 | $13 |
| Pravastatin | 34 | $481 | $14 |
| Sulfamethoxazole-Trimethoprim | 34 | $333 | $10 |
| Citalopram Hbr | 11 | $130 | $12 |
| Levothyroxine | 12 | $112 | $9 |
| Atorvastatin | 13 | $65 | $5 |
2021: 5 drugs
| Pantoprazole | 32 | $580 | $18 |
| Warfarin | 27 | $554 | $21 |
| Potassium Chloride | 11 | $430 | $39 |
| Lisinopril | 11 | $110 | $10 |
| Sulfamethoxazole-Trimethoprim | 14 | $45 | $3 |
2020: 3 drugs
| Nystatin | 13 | $569 | $44 |
| Lisinopril | 11 | $74 | $7 |
| Furosemide | 18 | $73 | $4 |
2019: 3 drugs
| Bumetanide | 11 | $486 | $44 |
| Warfarin | 24 | $409 | $17 |
| Furosemide | 11 | $53 | $5 |
2018: 4 drugs
| Warfarin | 23 | $349 | $15 |
| Losartan | 17 | $188 | $11 |
| Spironolactone | 15 | $139 | $9 |
| Furosemide | 14 | $25 | $2 |
Money from drug and device companies
$264 in 2025
| 2025 | 6 | 8 | None | $264 |
| 2024 | 6 | 8 | None | $421 |
| 2023 | 1 | 1 | None | $26 |
| 2022 | 2 | 7 | None | $251 |
| 2021 | 4 | 9 | None | $168 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | None | $108 | 3 payments
|
| Paragonix Technologies | Sherpapak | $44 | 1 payment
|
| Pfizer | Vyndaqel | $31 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $28 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $27 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $26 | 1 payment
|
See all 8 published payments
| Pfizer | Meals · 2025-12-08 | Vyndaqel | $31 |
| Novartis Pharmaceuticals | Meals · 2025-10-16 | Leqvio | $27 |
| Paragonix Technologies | Meals · 2025-10-01 | Sherpapak | $44 |
| Abbott Laboratories | Meals · 2025-09-11 | None | $34 |
| Abbott Laboratories | Meals · 2025-07-23 | None | $39 |
| Alnylam Pharmaceuticals | Meals · 2025-05-29 | Onpattro | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-11 | None | $26 |
| Abbott Laboratories | Meals · 2025-04-08 | None | $35 |
See earlier years (2024, 2023, 2022, 2021)
2024: $421
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $170 | 3 payments
|
| Impulse Dynamics (USA) | Optimizer | $129 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $42 | 1 payment
|
| CVRx | Barostim Neo System | $32 | 1 payment
|
| One Lambda | None | $29 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $21 | 1 payment
|
2023: $26
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $26 | 1 payment
|
2022: $251
| Abbott Laboratories | Heartmate Touch | $238 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $13 | 1 payment
|
2021: $168
| Abbott Laboratories | Heartmate Touch | $103 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $25 | 2 payments
|
| HeartFlow | Ffrct | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
Professional record
- NPI
- 1730275710
- Licence
- NM R58901
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- NM 36501387
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2006-10-05
- NPI last updated
- 2026-05-20
- NPI record certified
- 2026-05-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 201 Cedar St Se, Albuquerque, NM, 87106